Oral abrocitinib in the treatment of granuloma annulare: a case report
Aim: To evaluate the therapeutic efficacy and safety of JAK inhibitor abrocitinib in patients with localized granuloma annulare (GA) and to review the available cases documented in English.Methods: We presented a patient who had a persistent, localized granuloma anulare (GA) for one year and did not...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Dermatological Treatment |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2024.2313090 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846119639958945792 |
|---|---|
| author | Wenyan Liu Weifeng Chen Xin Tian Yihui Yu Junhui Zhu Jingyao Liang Xibao Zhang |
| author_facet | Wenyan Liu Weifeng Chen Xin Tian Yihui Yu Junhui Zhu Jingyao Liang Xibao Zhang |
| author_sort | Wenyan Liu |
| collection | DOAJ |
| description | Aim: To evaluate the therapeutic efficacy and safety of JAK inhibitor abrocitinib in patients with localized granuloma annulare (GA) and to review the available cases documented in English.Methods: We presented a patient who had a persistent, localized granuloma anulare (GA) for one year and did not respond to traditional therapies. This patient was treated with oral abrocitinib at a dosage of 150 mg daily.Results: After 6 weeks of treatment with abrocitinib, the patient exhibited notable symptom improvement with no new lesions. No adverse events or recurrences were reported during the 5-month follow-up period.Conclusions: Abrocitinib may be a promising and safe treatment option for patients with localized GA who do not respond to traditional therapies. |
| format | Article |
| id | doaj-art-a376a3474f0e4c57bac4f8b6f704ce89 |
| institution | Kabale University |
| issn | 0954-6634 1471-1753 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Dermatological Treatment |
| spelling | doaj-art-a376a3474f0e4c57bac4f8b6f704ce892024-12-16T22:53:48ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532024-12-0135110.1080/09546634.2024.2313090Oral abrocitinib in the treatment of granuloma annulare: a case reportWenyan Liu0Weifeng Chen1Xin Tian2Yihui Yu3Junhui Zhu4Jingyao Liang5Xibao Zhang6Institute of Dermatology, Guangzhou Medical University, Guangzhou, P.R. ChinaInstitute of Dermatology, Guangzhou Medical University, Guangzhou, P.R. ChinaInstitute of Dermatology, Guangzhou Medical University, Guangzhou, P.R. ChinaInstitute of Dermatology, Guangzhou Medical University, Guangzhou, P.R. ChinaInstitute of Dermatology, Guangzhou Medical University, Guangzhou, P.R. ChinaInstitute of Dermatology, Guangzhou Medical University, Guangzhou, P.R. ChinaInstitute of Dermatology, Guangzhou Medical University, Guangzhou, P.R. ChinaAim: To evaluate the therapeutic efficacy and safety of JAK inhibitor abrocitinib in patients with localized granuloma annulare (GA) and to review the available cases documented in English.Methods: We presented a patient who had a persistent, localized granuloma anulare (GA) for one year and did not respond to traditional therapies. This patient was treated with oral abrocitinib at a dosage of 150 mg daily.Results: After 6 weeks of treatment with abrocitinib, the patient exhibited notable symptom improvement with no new lesions. No adverse events or recurrences were reported during the 5-month follow-up period.Conclusions: Abrocitinib may be a promising and safe treatment option for patients with localized GA who do not respond to traditional therapies.https://www.tandfonline.com/doi/10.1080/09546634.2024.2313090Granuloma annulareJAK inhibitorsabrocitinib |
| spellingShingle | Wenyan Liu Weifeng Chen Xin Tian Yihui Yu Junhui Zhu Jingyao Liang Xibao Zhang Oral abrocitinib in the treatment of granuloma annulare: a case report Journal of Dermatological Treatment Granuloma annulare JAK inhibitors abrocitinib |
| title | Oral abrocitinib in the treatment of granuloma annulare: a case report |
| title_full | Oral abrocitinib in the treatment of granuloma annulare: a case report |
| title_fullStr | Oral abrocitinib in the treatment of granuloma annulare: a case report |
| title_full_unstemmed | Oral abrocitinib in the treatment of granuloma annulare: a case report |
| title_short | Oral abrocitinib in the treatment of granuloma annulare: a case report |
| title_sort | oral abrocitinib in the treatment of granuloma annulare a case report |
| topic | Granuloma annulare JAK inhibitors abrocitinib |
| url | https://www.tandfonline.com/doi/10.1080/09546634.2024.2313090 |
| work_keys_str_mv | AT wenyanliu oralabrocitinibinthetreatmentofgranulomaannulareacasereport AT weifengchen oralabrocitinibinthetreatmentofgranulomaannulareacasereport AT xintian oralabrocitinibinthetreatmentofgranulomaannulareacasereport AT yihuiyu oralabrocitinibinthetreatmentofgranulomaannulareacasereport AT junhuizhu oralabrocitinibinthetreatmentofgranulomaannulareacasereport AT jingyaoliang oralabrocitinibinthetreatmentofgranulomaannulareacasereport AT xibaozhang oralabrocitinibinthetreatmentofgranulomaannulareacasereport |